Authors
Loading...
Randomized trial demonstrates targeting TGF-β1/Smad3 reduces renal fibrosis in mice, suggesting new treatment avenues.
Sato et al. (2003) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: